Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Pregnancy Childbirth ; 18(1): 450, 2018 Nov 20.
Article in English | MEDLINE | ID: mdl-30458752

ABSTRACT

BACKGROUND: There is a paucity of epidemiological data on medication use in pregnancy in Cameroon. METHODS: Between March and August 2015, 795 pregnant women attending 8 urban and 12 rural hospitals in Cameroon for antenatal (ANC) or other care were interviewed on first trimester medication use using structured questionnaires. Multivariate logistic regression was used to analyse the association of 18 sociodemographic factors with medication use. RESULTS: A total of 582 (73.2%) women took at least one orthodox (Western) medication during the first trimester, 543 (68.3%) women a non-pregnancy related orthodox medication, and 336 (42.3%)women a pregnancy related orthodox medication. 44% of the women took anti-infectives including antimalarials (33.6%) and antibiotics (20.8%).The other most common medications were analgesics (48.8%) and antianaemias (38.6%). Sulfadoxine/pyrimethamine, contraindicated in the first trimester of pregnancy, was the most commonly used antimalarial(13% of women).0.2% of women reported antiretroviral use. Almost 80% of all orthodox medications consumed by women were purchased from the hospital. 12.8% of the women self-prescribed. Health unit and early gestational age at ANC booking were consistent determinants of prescribing of non-pregnancy related, pregnancy related and anti-infective medications. Illness and opinion on the safety of orthodox medications were determinants of the use of non-pregnancy related medications and anti-infectives. Age and parity were associated only with non-pregnancy related medications. CONCLUSION: This study has confirmed the observations of studies across Africa indicating the increasing use of medications during pregnancy. This is an indication that access to medicine is improving and more emphasis now must be placed on medication safety systems targeting pregnant women, especially during the first trimester when the risk of teratogenicity is highest.


Subject(s)
Drug Prescriptions/statistics & numerical data , Pregnancy Complications/drug therapy , Pregnancy Trimester, First , Prenatal Care/statistics & numerical data , Adult , Analgesics/therapeutic use , Anti-Bacterial Agents/therapeutic use , Antimalarials/therapeutic use , Cameroon/epidemiology , Drug Combinations , Female , Humans , Logistic Models , Multivariate Analysis , Pregnancy , Pregnancy Complications/epidemiology , Pregnancy Complications/etiology , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...